Navigation Links
Hormone Shows Potential as Diabetes Treatment in Mice
Date:4/25/2013

THURSDAY, April 25 (HealthDay News) -- A hormone that could lead to more effective diabetes treatment has been identified by researchers.

The hormone, called betatrophin, causes mice to produce insulin-secreting pancreatic beta cells at up to 30 times the normal rate. But it only produces insulin when the body needs it, according to the team at the Harvard Stem Cell Institute.

The researchers said their findings offer the potential for the natural regulation of insulin and a significant reduction in diabetes-related complications such as blindness and limb amputation.

The study is published in the April 25 online edition of the journal Cell and in its May 9 print issue.

Although the hormone shows promise in lab mice, much more work is needed before it could be considered as a treatment for diabetes in humans, the researchers noted. Results obtained in animal experiments often aren't attainable in trials with humans.

"If this could be used in people, it could eventually mean that instead of taking insulin injections three times a day, you might take an injection of this hormone once a week or once a month, or in the best case maybe even once a year," Doug Melton, co-director of the institute and co-chair of Harvard University's department of stem cell and regenerative biology, said in a university news release.

About 26 million Americans have type 2 diabetes, which causes people to slowly lose beta cells and the ability to produce sufficient amounts of insulin.

"Our idea here is relatively simple," Melton said. "We would provide this hormone, the type 2 diabetic will make more of their own insulin-producing cells, and this will slow down, if not stop, the progression of their diabetes. I've never seen any treatment that causes such an enormous leap in beta cell replication."

Along with its potential for treating type 2 diabetes, betatrophin might also have a role in treating type 1 diabetes, Melton said.

Unlike type 2 diabetes, which is associated with being overweight and sedentary, type 1 diabetes is an autoimmune disease that occurs most often in children and young adults.

More information

The U.S. National Institute of Diabetes and Digestive and Kidney Diseases has more about diabetes.

-- Robert Preidt

SOURCE: Harvard University, news release, April 25, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Hormones For Weight Control Article And Video Published by BetterDigestion.org
2. Researchers identify and block protein that interferes with appetite-suppressing hormone
3. Intermittent Hormone Treatment for Prostate Cancer Not the Best
4. Study Suggests Link Between Hormone Melatonin and Type 2 Diabetes
5. Princess Margaret breast cancer research finds new drug target companion prognostic test for hormone therapy resistance
6. More Evidence Shows Hormone Therapy May Increase Breast Cancer Risk
7. Artificial Ovaries Could Potentially Deliver Hormone Therapy
8. Mindfulness from meditation associated with lower stress hormone
9. Should Short Boys Take Growth Hormone?
10. Hormone Pills in Menopause May Carry Gallstone Side Effects
11. Study examines outcomes of screening mammography for age, breast density, hormone therapy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hormone Shows Potential as Diabetes Treatment in Mice
(Date:1/24/2017)... ... January 24, 2017 , ... “Who Would Have Dreamed: A Novel of Miracles”: ... woman who tried to understand its purpose in her life. “Who Would Have Dreamed: A ... powerful faith and a love of writing. , Sharon shares that she started ...
(Date:1/24/2017)... ... January 24, 2017 , ... ... networking-technology company founded by patient survivors, today announced formation of its first ... technologies and patient-inspired initiatives. , Like HCP founders, the global advisory ...
(Date:1/24/2017)... IL (PRWEB) , ... January 23, 2017 , ... ... is partnering with Plug and Play, the world’s largest start-up platform headquartered in ... companies a year. , OSF Ventures recently signed a three-year agreement to ...
(Date:1/24/2017)... ... January 23, 2017 , ... The TouchPoint Solution, parent company ... metrics into the product’s app. The data replicates and validates Co-Founder and ... just 30 seconds of using Buzzies, people experienced a 74 percent reduction in ...
(Date:1/23/2017)... ... 2017 , ... A Northwestern Pennsylvania addiction treatment center unveiled ... Rehabilitation & Recovery Center’s new website can be found at AlpineSpringsRehab.com . ... and retooled website. The treatment center has also revamped its social media strategy, ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... SPRINGFIELD GARDENS, N.Y. , Jan. 23, 2017 /PRNewswire/ ... an object from a blocked airway and prevented choking ... and disability awareness advocate to the LifeVac team as ... to have Steve join the LifeVac team," said ... is uniquely positioned to represent LifeVac and his mission ...
(Date:1/23/2017)... 23, 2017 7D Surgical announced today ... the U.S. Food and Drug Administration (FDA) and ... the North American commercial launch of its innovative ... surgery, the 7D Surgical System.  ... technologies and machine vision algorithms to eliminate the ...
(Date:1/23/2017)... -- Allergan plc, (NYSE: AGN ), a leading global ... Headache Academy (IHA). Designed to inspire a long-term commitment to ... a three-day, intensive overview on research and treatment options. This ... sponsor since the inception of IHA in North ... Europe in 2014. "Allergan is ...
Breaking Medicine Technology: